Horizon Discovery Group (LON:HZD) had its price target reduced by equities research analysts at N+1 Singer from GBX 250 ($3.45) to GBX 230 ($3.18) in a report released on Monday. The firm currently has a “buy” rating on the stock. N+1 Singer’s target price would suggest a potential upside of 24.32% from the company’s previous close.
Separately, Numis Securities reiterated a “buy” rating and set a GBX 300 ($4.14) target price on shares of Horizon Discovery Group in a report on Friday, December 29th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of GBX 236 ($3.26).
Horizon Discovery Group (LON:HZD) opened at GBX 185 ($2.56) on Monday. Horizon Discovery Group has a twelve month low of GBX 160 ($2.21) and a twelve month high of GBX 294 ($4.06). The firm has a market capitalization of $275.81 and a P/E ratio of -1,321.43.
In related news, insider Jonathan Milner purchased 90,492 shares of the business’s stock in a transaction that occurred on Wednesday, February 7th. The shares were bought at an average price of GBX 165 ($2.28) per share, for a total transaction of £149,311.80 ($206,288.75). Also, insider Susan Galbraith purchased 70,000 shares of the business’s stock in a transaction that occurred on Monday, February 5th. The stock was bought at an average price of GBX 179 ($2.47) per share, for a total transaction of £125,300 ($173,114.12).
ILLEGAL ACTIVITY NOTICE: This article was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.dispatchtribunal.com/2018/02/21/horizon-discovery-group-hzd-price-target-cut-to-gbx-230-by-analysts-at-n1-singer.html.
Horizon Discovery Group Company Profile
Horizon Discovery Group plc is a United Kingdom-based life science company. The Company uses gene editing and gene modulation application. Through the application of these technologies the Company enables researchers to alter almost any gene or modulate its function in human or mammalian cells to generate models that mimic the genetic abnormalities found in diseases such as cancer.
Receive News & Ratings for Horizon Discovery Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery Group and related companies with MarketBeat.com's FREE daily email newsletter.